U.S. Pharmaceutical Rapid Microbiology Testing Market Size & Outlook

Name: U.S. Pharmaceutical Rapid Microbiology Testing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The pharmaceutical rapid microbiology testing market in the United States is expected to reach a projected revenue of US$ 3,486.3 million by 2033. A compound annual growth rate of 11.4% is expected of the United States pharmaceutical rapid microbiology testing market from 2025 to 2033.

Biotechnology
- Microbiology
  - Pharmaceutical Rapid Microbiology Testing Market Outlook

U.S. pharmaceutical rapid microbiology testing product outlook (Revenue, USD million, 2021-2033)
- Instruments
- Reagents & Kits
- Software
- Accessories
U.S. pharmaceutical rapid microbiology testing technology outlook (Revenue, USD million, 2021-2033)
- Growth-based Testing
- Nucleic Acid-based Testing
- Cellular Component-based Testing
- Viability-based Testing
- Other Techniques
U.S. pharmaceutical rapid microbiology testing application outlook (Revenue, USD million, 2021-2033)
- Bioburden testing
- Sterility testing
- Endotoxin testing
- Other Applications
- Environmental monitoring
- Pyrogen testing
- Mycoplasma testing
- Microbial identification
U.S. pharmaceutical rapid microbiology testing test type outlook (Revenue, USD million, 2021-2033)
- Traditional/Conventional Testing
- Rapid Testing

U.S. Pharmaceutical Rapid Microbiology Testing Market Size & Outlook

Data Tree

Sign up - it's easy, and free!